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Abstract
Background: Camptodactyly-arthropathy-coxa vara-pericarditis (CACP, OMIM: #208250) syndrome is a rare
autosomal recessive disease that can be difficult to recognise not only because of its wide clinical variability
but also because of its clinical resemblance to juvenile idiopathic arthritis (JIA). PRG4 is the only gene so far
known to be associated with CACP syndrome. Children with CACP syndrome lack the glycoprotein lubricin
due to recessive mutations in PRG4. Lubricin serves as a lubricant in joints, tendons and visceral cavities
(pleural cavity, pericardium) and inhibits synovial proliferation. Children with CACP syndrome suffer from
congenital camptodactyly, arthropathy, coxa vara and sometimes pericarditis. This report concerns a child with CACP
syndrome complicated by protein-losing enteropathy (PLE), caused by constrictive pericarditis and so contributes to
knowledge of the presentation of CACP syndrome.
Case Presentation: A 10- year-old girl with consanguineous parents suffered from congenital camptodactyly and
progressive swollen and painful joints. Her father and his sister had similar childhood-onset joint complaints. Laboratory
tests showed no signs of inflammation but showed persistent low protein- and IgG- levels, indicating a secondary
immunodeficiency. Increased alpha antitrypsin clearance confirmed PLE. Abdominal ultrasound with Doppler showed
hepatomegaly and portal hypertension. Echocardiography suggested constrictive pericarditis. However, heart
catheterization could not confirm this. Ultrasound and X-ray examination of the joints combined with a puncture of
the synovial fluid were performed. These results, combined with the clinical presentation and the consanguinity,
suggested CACP syndrome. Due to excessive enteral protein losses, the patient was treated with Cotrimoxazol
prophylaxis and immunoglobulin supplements. These supplements were inadequate to achieve normal IgG values. As
constrictive pericarditis with subsequent PLE was the best explanation for the excessive IgG losses, pericardiectomy
was performed with good results. Genetic testing in our patient was complicated but revealed a pathogenic mutation
within the repeat sequence in exon 7 of the PRG4 gene.
Conclusion: PLE resulting from constrictive pericarditis can be a complication of CACP syndrome. As serious
complications can arise from the resulting secondary immunodeficiency, we recommend regular evaluation of clinical
symptoms of constrictive pericarditis and PLE in children with CACP syndrome.
Keywords: Camptodactyly-arthropathy coxa vara-pericarditis (CACP) syndrome, Protein-losing enteropathy (PLE),
Hypogammaglobulinaemia, Secondary immunodeficiency, Constrictive pericarditis, Juvenile idiopathic arthritis (JIA),
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Background
CACP syndrome is a rare autosomal recessive disorder
characterized by a triad of camptodactyly, childhood
non-inflammatory arthropathy with synovial hyperplasia
and coxa vara. Occasionally non-inflammatory pericardi-
tis and pleural effusion are present. CACP syndrome has
been found in different ethnic populations [1, 2]. Due to
its rarity, CACP syndrome is probably under-diagnosed,
making it difficult to estimate prevalence rates [1]. Fea-
tures of CACP syndrome mimic juvenile idiopathic arth-
ritis (JIA), and this may lead to misdiagnosis and
incorrect treatment [1, 3].
The pathophysiology of CACP syndrome is not com-
pletely known. Patients affected by CACP syndrome lack
the glycoprotein lubricin. Its formation involves tran-
scription of the proteoglycan 4 gene (PRG4), which is
expressed not only in joints but also in pericardial and
pleural cavities as well as the liver, kidneys and skeletal
muscles. The PRG4 gene is located on chromosome
1q31.1 (OMIM:*604283). Currently, twenty-two muta-
tions have been reported (HGMD professional 2015.3)
[4]. It is predicted that all mutations will lead to a pre-
mature stop codon, resulting in the absence of func-
tional lubricin [1–3, 5].
In joints, lubricin is produced by fibroblastic synovio-
cytes, articular chondrocytes and cells lining articular
cartilage and tendon-sheaths, including the covering
outer aspects of tendons. Lubricin has lubricating prop-
erties and the capacity to regulate cell growth, and it
protects the cartilage surface from protein deposits and
friction-induced damage [1, 2, 6]. The absence of lubri-
cin causes synovial hyperplasia, which can damage joint
cartilage by inhibiting the normal exchange of nutrients
and waste products and by invading the articular cartil-
age surface [7]. Tissue remodelling and calcification of
tendon-sheaths may account for the development of
camptodactyly [8].
In addition to proliferative synovitis, biopsies of human
synovia show deposits of an eosinophilic amorphous
material, stromal multinucleated giant cells (originally
macrophages) and a paucity of inflammatory cells [6]. The
presence of these giant cells is presumably due to the
infiltration and accumulation of macrophages, possibly
aggravated by the deposit of eosinophilic material, not to
proliferation. The exact source of this eosinophilic
material is unclear [6]. Synovial fluid in CACP syndrome
is viscous, clear, honey-coloured and low in cell count [9].
As fibrosis is observed in pericardial biopsies, it is
likely that lubricin serves as an anti-adhesive between the
visceral and parietal pericardium. The role of lubricin in
the liver, kidneys and skeletal muscles is unclear [2, 10].
The clinical manifestations of CACP syndrome can
vary, even within families [3]. The slow progressive onset
of CACP syndrome can cause an initially incomplete
clinical picture [7]. However, camptodactyly (85–100 %)
and arthropathy (100 %) are found consistently [5, 11].
Camptodactyly is symmetrical with a variable distribu-
tion. Any finger or toe can be affected. It can be con-
genital or develop during infancy [3, 11]. Arthropathy
is symmetrical and principally involves the large joints
(wrists, knees, ankles, elbows and hips). The wrist is
the first and most frequently affected joint. The knees are
also often affected. Coxa vara is present in 50–90 % of
cases, is progressive and becomes more pronounced with
age [1, 3, 11]. Spine abnormalities (lordosis, scoliosis and
kyphosis) can also occur [3]. Normally, the cervical spine
is not affected [9]. Children usually complain of swollen
joints, due to hydrops and synovial thickening (without
signs of inflammation), joint contractures, restricted
movement and sometimes musculoskeletal pains. Non-
inflammatory pericarditis occurs in up to 30 % of
published cases and has a wide clinical variability,
from a self-limiting course to constrictive pericarditis
requiring surgical intervention [1, 3, 12].
This report concerns a young female patient with
protein-losing enteropathy (PLE) and resultant hypo-
gammaglobulinaemia due to constrictive pericarditis in
CACP syndrome. As far as can be established, PLE has
never been described as part of the symptom complex of
CACP syndrome. Due to this unusual complication, the
diagnosis of pericarditis and subsequently CACP syn-
drome was challenging. This report contributes to know-
ledge of the presentation of CACP syndrome and
provides insight into possible complications.
Case presentation
A ten-year-old girl of Turkish origin with consan-
guineous parents (for pedigree, see Additional file 1:
Figure S1) presented at the paediatric ward of a gen-
eral hospital with arthralgia. A flexion contracture of
the right-hand little finger had been present since
early infancy (Fig. 1) and she had been suffering
Fig. 1 Right hand of the patient. Fifth finger camptodactyly
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from progressively swollen and painful knees, wrists,
elbows and ankles since the age of three. She regu-
larly had a swollen face and in the past she suffered
from recurrent respiratory infections. Her father and
his sister also experienced similar childhood-onset
joint complaints (Fig. 2). The father had been diag-
nosed with JIA as a child.
On examination, our patient had a camptodactyly of
her right fifth finger and a mild curvature of her left
index finger. Her metacarpal joints, right wrist, both an-
kles and both knees were swollen. Extension of both el-
bows was limited. Iridocyclitis was not present. In view
of her joint complaints and recurrent respiratory infec-
tions, an autoimmune disease and immunodeficiency
were suspected. Laboratory tests showed no signs of in-
flammation. Reumatoidfactor, ANA and anti-CCP were
all negative. Total IgG and total albumin were low (IgG
1.57 g/l and albumin 20 g/l), indicating a secondary im-
mune deficiency.
During a follow-up physical examination, an enlarged
liver was found, though no heart murmur was heard.
Laboratory tests revealed normal liver enzymes and per-
sistently low IgG with normal IgM and IgA. In CT im-
aging no intrapulmonary lesions were found. However,
pleural and pericardial effusion of unknown origin were
present. The girl was referred to our University Medical
Centre for further diagnostic tests.
With regard to protein loss, faecal analysis showed an
increased alpha antitrypsin clearance, suggesting PLE.
An abdominal ultrasound with Doppler was conducted
and showed hepatomegaly and portal hypertension (re-
versed flow in portal vein). A full cardiac analysis was
consequently carried out. The electrocardiogram was
normal. Echocardiography showed moderate pericardial
effusion and a septal diastolic bounce, suggesting con-
strictive pericarditis. The Doppler measurements were
not conclusive. Because we could not confirm a cardiac
origin of the portal hypertension, we decided to exclude
a hepatogenic origin of the portal hypertension first. A
percutaneous liver biopsy revealed a-specific fibrosis
interpreted as chronic venous congestion. To determine
intra-cardiac pressure to confirm constrictive pericardi-
tis, heart catheterization was then performed, which
showed elevated venous pressures (mean 22 mm of mer-
cury), equalization of end-diastolic pressures in all car-
diac chambers and a right ventricular pressure of 31 mm
of mercury (upper limit of normal). Kussmaul’s sign was
positive. As the presence of the square root sign of the
right ventricle was inconsistent and enhanced ventricu-
lar interdependence was absent, we could not confirm
the diagnosis of constrictive pericarditis. Moreover, a
thickened pericardium was not seen on a subsequent
cardiac MRI.
Since the diagnosis of constrictive pericarditis could
not be confirmed, other diagnoses were reconsidered.
Investigations to rule out JIA and other autoimmune
diseases causing polyarthritis were undertaken, including
an ultrasound of the joints and a puncture of the syn-
ovial fluid. The synovial capsule seemed thickened. The
synovial fluid was mildly honey-coloured and showed
some multinucleated macrophages (CD68 positive) with-
out signs of inflammation. Inflammatory arthritis was
thus excluded. CACP syndrome was suggested and fur-
ther evaluation was performed. X-ray examination
showed coxa vara, peri-articular osteopenia and flattened
metacarpal and phalangeal joints. As the overall clinical
presentation and results were suggestive of CACP syn-
drome, the girl and her father were referred for genetic
testing and counselling. Meanwhile the patient was
treated with immunoglobulin supplements and Cotri-
moxazol prophylaxis. Because high doses of IgG were
needed to compensate for her losses (1.6 g/kg/28 days),
intravenous administration was chosen for better toler-
ance of treatment despite potential pharmacokinetic dis-
advantages. However, due to excessive enteral protein
loss, normal serum IgG values could not be achieved. As
constrictive pericarditis with subsequent PLE was the
best explanation for the excessive IgG losses, this indi-
cated a pericardiectomy. During this procedure a thick-
ened parietal epicardium and fibrotic visceral epicardial
layer on the right and left ventricle were removed, after
which central venous pressure dropped from 14 to
7 mm of mercury. After this intervention the PLE and
portal hypertension were resolved quickly. Supplementa-
tion of intravenous immunoglobulins was discontinued
successfully. Repetitive measurements of serum albumin
and IgG were all within normal ranges, indicating a full
stop of the PLE. One year after the pericardiectomy, all
Fig. 2 Right hand of the patient's father. Camptodactyly in all
fingers. The father has a more extended form of camptodactyly. It
demonstrates the variable presentation of the camptodactyly and
clinical variability of the CACP syndrome even within families
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echocardiographic measurements were normal, meaning
no effusion, normal wall motion and normal Doppler
measurements.
Clinically, the girl is in good condition. Besides the
camptodactyly and limited extension of her elbow, no
other joint complains were left. Additionally, the oedema
and joint swellings disappeared.
With regard to the genetic testing, the genome-
wide array analysis (Affymetrix CytoScan HD array
platform) of the girl and her father showed a total of
83 Mb of shared homozygosity, including the PRG4
gene (see Additional file 2: Figure S2). The homozy-
gous regions did not contain other candidate genes
likely to explain the phenotype. Sanger sequence ana-
lysis of the coding sequence of PRG4 was performed on
the DNA of the girl in our laboratory (NM_005807.3). All
exons in the gene were eventually tested. Sixty percent of
the PRG4 gene was sequenced and analysed successfully
by conventional PCR and Sanger sequencing, including
complete exons 1–6 and 8–13. As the analysis of
exon 7 encountered technical problems and no pathogenic
mutation was found in the PRG4 gene, diagnostic exome
sequencing was carried out essentially as previously
described in literature (Genome Diagnostics Radboudumc,
gene package ‘multiple congenital anomalies’, version
DG2.3×) [13]. A homozygous pathogenic one basepair
deletion, c.1290del (p. (Thr431fs), was identified in
exon 7 of the PRG4 gene, resulting in a premature stop
codon (see Additional file 3: Figure S3). No other
pathogenic mutations were identified in the disease
gene package.
Discussion
This report concerns a girl with CACP syndrome com-
plicated by PLE as a consequence of constrictive pericar-
ditis. The diagnostic process was challenging for a
number of reasons.
PLE has several causes. With constrictive pericarditis,
elevated central venous pressure causes congestion of
the intestinal lymphatic drainage, leading to the direct
leakage of proteins, including IgG, into the intestinal
lumen [14]. Constrictive pericarditis usually results in
hemodynamic changes that are related to fluid overload
(e.g. peripheral oedema, elevated central venous pres-
sure, hepatomegaly and pleural effusion), decreased
cardiac output (e.g. fatigue, dyspnea on exertion) and
an abnormal thickening of the pericardium >3 mm
[14, 15]. However, in this case, PLE was the only principal
sign of constrictive pericarditis. Hypoproteinemia was the
most likely cause of the pleural effusion and peripheral
oedema.
Additionally, our patient had joint complaints that
were similar to JIA. As no signs of inflammation were
found in the blood or the synovial fluid, JIA was unlikely
to be the cause of these joint complaints. Family history,
consanguinity and early-onset camptodactyly provided
significant clues for the diagnosis of this case [11, 12].
Radiological examinations also assisted greatly. Several
distinguishing features characterise CACP syndrome:
periarticular osteopenia with increased joint space in
the affected joints, squaring or flattening of the meta-
carpal and phalangeal heads, coxa vara with short
femoral necks and flat, irregular femoral heads and,
occasionally, highly distinguishing intraosseus fluid-
filled herniations of the acetabulum [1, 9, 11, 12].
Radiologic features of CACP can mimic the acute
non-erosive phase of JIA [9, 12]. However, in a more
developed stage, inflammation caused by JIA results
in the destruction of the joint and the narrowing of
the joint space. These types of erosion are not seen
in CACP syndrome [9].
New insights into the role of lubricin in arthralgia re-
veal that CACP syndrome is more related to rheuma-
toid arthritis (RA) and osteoarthritis (OA) than
previously thought. In humans with RA or OA and in
animal joint injuries, changes in lubricin’s abundance
and/or function have been found. This acquired form
of lubricin deficiency in RA and OA provides new in-
sights into the protective function of lubricin in arthral-
gia and explains how CACP syndrome mimics clinical
features of JIA [8, 10, 16].
The girl was given a clinical diagnosis of CACP syn-
drome. Subsequent extensive genetic testing was per-
formed to confirm the clinical diagnosis. Exome
sequencing identified a homozygous pathogenic muta-
tion, which was identified in exon 7 of the PRG4 gene.
This mutation is also predicted to lead to a premature
stop codon, resulting in the absence of functional lubri-
cin. Because the mutation was located in the part of
exon 7 that failed amplification, it had not been previ-
ously detected by Sanger sequencing. This part of exon
7 (c.1128-2733) was unsuccessfully amplified by Sanger
sequencing due to its repetitive nature, as mentioned
elsewhere [7]. To the best of our knowledge, this
mutation has not been reported before. Confirming
the carrier status of the mother would have further
supported the hereditary nature of the mutation that
was found. Since in our laboratory exome sequencing
is the only technique to investigate exon 7, we have
not been able to confirm the affected status of the
father and the carrier status of the mother through
an affordable technique. Although there is no direct
proof that the mutation in the girl originates from
both parents, the consanguinity (see the pedigree in
Additional file 1: Figure S1) and the shared homozy-
gous region of the girl and her father are indirect
evidence that the girl inherited this mutation from
her parents.
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From a therapeutic perspective, there are no accounts
yet of effective arthropathy treatment for children with
CACP syndrome. In literature two cases are reported in
which a total hip arthroplasty was carried out in re-
sponse to severe disability problems. This intervention
resulted in the relief of pain and improvement of func-
tion [17]. CACP symptoms do not respond to anti-
inflammatory drugs. In general, patients may benefit
from vitamin D and calcium supplementation [1].
There are indications that the intra-articular injection
of recombinant lubricin can prevent synovial thicken-
ing and the degeneration of cartilage in OA and CACP
syndrome. Rhee et al. have demonstrated that purified
and recombinant lubricin in vitro prevents protein de-
position onto cartilage surface and inhibits the
adhesion-dependent cell growth of synoviocytes in
lubricin-mutant mice [8]. Flannery et al. evaluated the
intra-articular administration of a purified preparation
of recombinant lubricin versus a phosphate-buffered
saline in an experimental rat model of OA. In this
model, the medial meniscus was cut through the full
thickness, causing a complete rupture. After 4 weeks of
treatment, local administration of lubricin had a signifi-
cant disease-modifying and chondro-protective effect
on the progression of OA [18]. Recombinant lubricin
may feature in future treatment options for CACP
patients, although clinical studies are required and
technical problems regarding local delivery must be
overcome [16].
Conclusion
To the best of our knowledge, this is the first account of
a case of massive PLE resulting from constrictive
pericarditis that presents as a complication in a patient
with CACP syndrome. Exome sequencing revealed a
pathogenic mutation within the repeat sequence in
exon 7 of the PRG4 gene, a region that failed amplifi-
cation by PCR and Sanger sequencing. It is possible
for PLE to be the only sign of constrictive pericardi-
tis. As serious complications can arise from the
resulting secondary immunodeficiency, it is advisable
to examine children with CACP syndrome regularly
for clinical signs of PLE and constrictive pericarditis.
In the case of a positive result, a referral for full cardiac
examination and an evaluation of immunoglobulins is
recommended.
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Additional file 1: Figure S1. Pedigree showing consanguinity. Index is
indicated with the arrow. Individuals in black suffer from arthropathy
(starting early in childhood) and camptodactyly. (DOCX 68 kb)
Additional file 2: Figure S2. Shared regions of homozygosity. Table
shows the shared homozygous regions between the patient and her
father and the number of OMIM autosomal recessive disease genes that
reside within these homozygous regions. The two largest regions of
homozygosity are a 45 Mb homozygous region on chromosome
1q22q32.1—including PRG4—and a 24 Mb homozygous region on
chromosome 8. (DOCX 63 kb)
Additional file 3: Figure S3. Graphical overview of the genomic
structure of PRG4 (NM_005807.4). (A) Red stripes indicate mutations that
are described in the Human Gene Mutation Database. Sequence depth is
visualized in the lower part in light gray. Note the difficult-to-sequence
repeat region of exon 7, indicated by less sequence depth. (B) Zoom-in
of the BAM-files of our patient, showing the reads containing the
homozygous mutation c.1290del (arrow). Diagnostic exome sequencing
was performed, as described in detail by Neveling et al., using an Illumina
HiSeq2000TM sequencer at BGI-Europe (Copenhagen, Denmark) [13]. Read
alignment to the human reference genome (GrCH37/hg19) and variant
calling was performed at BGI using BWA and GATK software, respectively.
Variant annotation was performed using a custom-designed in-house
annotation and variant prioritization pipeline. All PRG4 exons were analyzed
using this test. (PPTX 731 kb)
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